Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

NCT05098704 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Scleroderma
Systemic Sclerosis

Interventions

DRUG: clopidogrel treatment
DRUG: Placebo

Sponsor

University Hospital, Bordeaux

Collaborators

[object Object]